ABSTRACT
A new polyacrylate, poly(methylidenelactide), with high thermal stability and derived from biobased resources is reported. This polymer is formed from the radical polymerization of a modified lactide derivative and represents one of the few examples of an acrylic from which the entire mass is bioderived and is made from a simplistic synthesis. Furthermore, poly(methylidenelactide) serves as a foundation for a platform of new acrylic structures, owing to pendant cyclic diesters that are susceptible to postpolymerization modification via simple transesterification chemistry. Several examples of unique acrylics made from poly(methylidenelactide) are synthesized and characterized.
ABSTRACT
A modified rheokinetic technique was developed to monitor the polymerization of healing monomers in a microcapsule-based, self-healing mimicking environment. Using this modified technique, monomers active toward ring-opening metathesis polymerization (ROMP) were either identified or disregarded as candidates for incorporation in self-healing polymers. The effect of initiator loading on the quality and speed of healing was also studied. It was observed that self-healing polymers have upper and lower temperature limits between which the healing mechanism performs at optimal levels. Also, a study of the quality of healing cracks of different thicknesses was performed, and it was discovered that above a critical crack thickness value, the quality of self-healing diminishes substantially; reasons for this phenomenon are discussed in detail.
ABSTRACT
While original epoxy resin-based self-healing systems used the commercially available endo-isomer of dicyclopentadiene (DCPD), the exo-stereoisomer is known to have much faster olefin metathesis reaction rates with first-generation Grubbs' catalyst. Here, we measure the energy to failure of healed specimens as a function of healing time and compare the kinetics of damage repair for endo- and exo-DCPD, and mixtures of the two isomers. Using catalyst loading levels previously reported to be effective for endo-DCPD, exo-DCPD was found to heal approximately 20 times faster than the endo-isomer, but with a lower healing efficiency. The fracture toughness of the repaired specimens decreased when the exo content of the blends was greater than 40% and, for the pure exo-DCPD, when the catalyst loadings were below 1%. Possible causes of the reduced healing efficiencies of the exo-DCPD healing agent are discussed.
